Growth Hormone Deficiency, Pediatric

Endocrinology
3
Pipeline Programs
1
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
3
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Ascendis Pharma
Ascendis PharmaCA - Palo Alto
3 programs
3
Once weekly subcutaneous injection of TransCon hGHPhase 31 trial
TransCon hGHPhase 31 trial
TransCon hGHPhase 31 trial
Active Trials
NCT02781727Completed162Est. Jan 2019
NCT03305016Completed146Est. Mar 2019
NCT03344458Completed298Est. Feb 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Ascendis PharmaTransCon hGH
Ascendis PharmaTransCon hGH
Ascendis PharmaOnce weekly subcutaneous injection of TransCon hGH

Clinical Trials (3)

Total enrollment: 606 patients across 3 trials

NCT03344458Ascendis PharmaTransCon hGH

A Long-Term Trial Investigating Safety and Efficacy of TransCon hGH in Children With Growth Hormone Deficiency Who Have Completed a Prior TransCon hGH Clinical Trial

Start: Dec 2017Est. completion: Feb 2023298 patients
Phase 3Completed
NCT03305016Ascendis PharmaTransCon hGH

A Safety, Tolerability and Efficacy Study of TransCon hGH in Children With Growth Hormone Deficiency

Start: Nov 2017Est. completion: Mar 2019146 patients
Phase 3Completed
NCT02781727Ascendis PharmaOnce weekly subcutaneous injection of TransCon hGH

A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)

Start: Dec 2016Est. completion: Jan 2019162 patients
Phase 3Completed

Related Jobs in Endocrinology

Research Associate I/II - Biology

Marea Therapeutics
South San Francisco
1w ago
$90K - $120K/yr

Associate Director, Clinical Operations

Marea Therapeutics
South San Francisco
3w ago
$190K - $210K/yr

Associate Director/Director, Regulatory Affairs

Marea Therapeutics
South San Francisco
1mo ago
$185K - $240K/yr

Medical Science Liaison (rare diseases)

Amgen
Poland - Lódz
1mo ago

Senior/Executive Director, Analytical Development

Marea Therapeutics
South San Francisco
1mo ago
$250K - $295K/yr

Senior Clinical Scientist - Job ID: 1845

Ascendis Pharma
Palo Alto, California (Hybrid)
2mo ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 late-stage (Phase 3) programs — potential near-term approvals
1 companies competing in this space

Related Indications

Acromegaly(67)Growth Hormone Deficiency(39)Growth Hormone Disorder(37)Hypogonadism(21)Secondary Hyperparathyroidism(13)Hypoparathyroidism(12)Thyroid Eye Disease(11)Adult Growth Hormone Deficiency(10)Hypothyroidism(9)Cushing's Syndrome(9)